United Kingdom · Series B startup

Who invested in Karus Therapeutics

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$7.6Mraised across 1 round since 2012, from 1 source

Latest round
Series B, $7.6MSept 2012
Investors
4
See who backed them

The rounds

  1. Sept 2012

Everyone who backed them

SV Life SciencesVC firm1round
Novo Holdings A/SGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Karus Therapeutics

Who invested in Karus Therapeutics?

Karus Therapeutics's investors include SV Life Sciences, New Leaf Venture Partners, Novo Holdings A/S and International Biotechnology Trust Plc.

How much has Karus Therapeutics raised?

Karus Therapeutics has raised $7.6M across 1 round since 2012.

When did Karus Therapeutics last raise?

Karus Therapeutics's most recent round was a Series B of $7.6M in Sept 2012.

What was Karus Therapeutics's biggest round?

Its most recent round, $7.6M in Sept 2012, is also its largest on record.

Who backed Karus Therapeutics first?

Karus Therapeutics's first round on record, in Sept 2012, was backed by SV Life Sciences, New Leaf Venture Partners and Novo Holdings A/S and 1 others.

What stage is Karus Therapeutics at?

Karus Therapeutics's latest named round is a Series B, in Sept 2012.

Where is Karus Therapeutics based?

Karus Therapeutics is based in the United Kingdom.

Companies like Karus Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.